Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

R pyocin sensitivity of Pseudomonas aeruginosa clinical isolates from different disease types.

Journal of medical microbiology - 1 Jun 2026

Deng Yanhan, Wang Meggie, Chopra Chandni, Shelburne Samuel A, Miller William R, Kirienko Natalia V

Abstract excerpt

Introduction. Multidrug-resistant infections by the opportunistic pathogen Pseudomonas aeruginosa are common in healthcare settings but are increasingly difficult to treat due to high rates of antimicrobial resistance.Hypothesis/Gap Statement. Interest has developed in using R pyocins, bacteriocins produced by P. aeruginosa, as a species-specific treatment. We hypothesize that understanding the connections...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Bacterial Agents
Share to Genotype

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Microbial Sensitivity Tests

Share to O Antigens

Share to Phylogeny

Share to Pseudomonas aeruginosa

Share to Pseudomonas Infections

Source

Open in PubMed Open full text

Identifiers

PMID: 42329126
DOI: 10.1099/jmm.0.002179
PMCID: PMC13286288

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 24 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

R pyocin sensitivity of Pseudomonas aeruginosa clinical isolates from different disease types.PMID 42329126Read ↗

Heterogenous susceptibility to R-pyocins in populations of <i>Pseudomonas aeruginosa</i> sourced from cystic fibrosis lungsSemantic proximity Read ↗

A Panel of Diverse <i>Pseudomonas aeruginosa</i> Clinical Isolates for Research and DevelopmentSemantic proximity Read ↗

High prevalence of lipopolysaccharide mutants and R2-pyocin susceptible variants in Pseudomonas aeruginosa populations sourced from cystic fibrosis lung infectionsSemantic proximity Read ↗

Role of R5 Pyocin in the Predominance of High-Risk <i>Pseudomonas aeruginosa</i> IsolatesSemantic proximity Read ↗

Susceptibility to R-pyocins of Pseudomonas aeruginosa clinical isolates from cystic fibrosis patientsSemantic proximity Read ↗

High prevalence of lipopolysaccharide mutants and R2-Pyocin susceptible variants in <i>Pseudomonas aeruginosa</i> populations sourced from cystic fibrosis lung infectionsSemantic proximity Read ↗

Lipopolysaccharide as shield and receptor for R-pyocin-mediated killing in Pseudomonas aeruginosa.Semantic proximity Read ↗

Emerging pathogens in urinary tract infections: virulence and phenotypic characterization of Pseudomonas aeruginosa strains.Semantic proximity Read ↗

F-type Pyocins are Diverse Non-Contractile Phage Tail-Like Weapons for Killing <i>Pseudomonas aeruginosa</i>Semantic proximity Read ↗

Pseudomonas aeruginosa: a clinical and genomics updateSemantic proximity Read ↗

Emerging Pathogens in Urinary Tract Infections: Virulence and Phenotypic Characterization of <i>Pseudomonas aeruginosa</i> strainsSemantic proximity Read ↗

Mapping genetic and phenotypic diversity of <i>Pseudomonas aeruginosa</i> across clinical and environmental isolation sitesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.